Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Xencor
Sort By
Newest First
1 / 1
Leadership
Xencor Announces the Planned Retirement of Chief Medical Officer Paul Foster, M.D.
Xencor, Inc.
PR-M07-19-NI-006-2425
Jul 03, 2019
License Agreement
Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates
Selexis SA
PR-M03-18-NI-009
Mar 02, 2018
1 / 1
